Tritonix.ai

News / Taiwan / cnyes

Taiwan Ranks First in Global Healthcare Index for 8th Year; Premier Cho Pledges to Build New 'National Shield' in Biotech

Health Technology · Biotechnology · cnyes · 2026-08-24

Premier Cho Jung-tai announced that Taiwan's biotech sector will be the next pillar of the economy, backed by massive AI infrastructure investments.

What Happened

Strategic Vision: Premier Cho Jung-tai addressed the Biotech Industry Strategy Advisory Committee, highlighting Taiwan's potential to establish a new "national shield" industry beyond semiconductors. He emphasized the nation's leadership in smart healthcare, drug development, and intelligent agriculture.

Economic Impact: Taiwan has topped the Global Healthcare Index for eight consecutive years, with the biotech sector generating over NT$85 billion in revenue last year. The government has allocated NT$40.6 billion for AI-related construction in the upcoming budget to further accelerate this growth.

Policy Initiatives: The administration is rolling out "AI New Ten Major Constructions" and "Long-term Care 3.0" to integrate digital health into daily life. These initiatives focus on AI-driven drug discovery and remote medical services to improve the quality of life for an aging population.

Future Outlook: With President Lai Ching-te's medical background driving policy execution, the government aims to shift focus from average life expectancy to healthy life expectancy. Officials are refining regulations and sustainability frameworks to ensure the biotech sector remains a global leader.

Read original

More in Health Technology

Medigen Vaccine Biologics Partners with Global and Local Firms for Next-Gen Enterovirus Vaccine

Health Technology · cnyes · 2026-08-24

Medigen Vaccine Biologics has launched a dual-track strategy to develop a multi-valent enterovirus vaccine by partnering with international and local experts.

6547, 6939

JieLiKang to Debut on Emerging Stock Market on Aug 31, Targeting Soft Tissue Repair Market

Health Technology · cnyes · 2026-08-24

Biotech firm JieLiKang (7686) is set to list on the emerging stock market on August 31, leveraging its proprietary LipoShell and HeliBarb platforms to capture growth in breast reconstruction and medical aesthetics.

7686

PharmaEssentia's Ropeg Receives Japanese Approval for All ET Patients

Health Technology · cnyes · 2026-08-24

PharmaEssentia has secured Japanese regulatory approval for its drug Ropeg to treat all patients with essential thrombocythemia, marking a significant milestone.

6446

Latest in Taiwan

Yuanta's 00940 ETF Boosts Monthly Dividend to Record High of NT$0.055

Miscellaneous · cnyes · 2026-08-24

The Yuanta Taiwan Value High Dividend ETF (00940) has raised its monthly payout to a record NT$0.055 per share, offering an annualized yield of 5.3%.

00940

Surging Treasury Yields Spark Alarm: Why AI Tech Stocks Remain a Buy

Electronic Technology · economic_daily · 2026-08-24

Despite concerns over 19-year high Treasury yields, analysts argue that government intervention will stabilize rates, creating a prime buying opportunity for AI-related tech stocks.

3081, 3163, 3363, 4979, 6830

Taiwan Stocks Consolidate: Analysts See Buying Opportunities in AI Leaders

Electronic Technology · economic_daily · 2026-08-24

As the Taiwan stock market undergoes a period of low-volume consolidation, analysts suggest that pullbacks in AI heavyweights like TSMC and Foxconn present strategic entry points.

Fubon Financial Sees AI and Semiconductor Lending Boom Lasting Through H1 2027

Finance · cnyes · 2026-08-24

Fubon Financial reports strong growth in corporate lending driven by AI and semiconductor demand, with management optimistic about the outlook through mid-2027.

2881